We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Future Muscle-Powered Surgical Robots Could Perform Minimally Invasive Procedures inside Body

By HospiMedica International staff writers
Posted on 09 Apr 2024
Print article
Image: The new spring shown in Petri dish maximizes the work of natural muscles (Photo courtesy of MIT)
Image: The new spring shown in Petri dish maximizes the work of natural muscles (Photo courtesy of MIT)

Muscles, as nature's perfect actuators, outperform most synthetic counterparts in power and precision relative to their size, possessing the unique ability to repair and strengthen through exercise. This remarkable efficiency has inspired engineers to harness natural muscles to power robots with natural muscles, resulting in "biohybrid" robots capable of performing actions such as walking, swimming, pumping, and gripping through muscle-based actuators - devices that turn energy into motion. However, the diversity in robot designs has created the need for a universal approach to optimize muscle utilization across various robot models. Now, engineers have developed a spring-like device, termed a "flexure," which serves as a basic skeleton-like module suitable for almost any muscle-driven robot.

The new spring, or “flexure,” has been designed by engineers at MIT (Cambridge, MA, USA) to extract maximum work out of any attached muscle tissues. Similar to a perfectly weighted leg press machine, this device significantly enhances the amount of movement naturally produced by a muscle. Upon fitting a ring of muscle tissue onto the device, similar to a rubber band being stretched around two posts, they found that the muscle pulled on the spring, reliably and repeatedly, and stretched it five times more, in comparison with other earlier device designs. The device was also found to accurately measure muscle performance and endurance.

After experimenting with different muscle contraction frequencies (such as stimulating the bands to contract once versus four times per second), they found that the muscles became tired at higher frequencies and failed to generate as much pull. The engineers consider the flexure design as a new building block that can be combined with other flexures to build artificial skeletons of any configuration. These skeletons can then be fitted with muscle tissues to power their movements. The team is currently exploring ways to adapt and combine flexures to develop precise, articulated, and dependable robots powered by natural muscles.

“An example of a robot we are trying to build in the future is a surgical robot that can perform minimally invasive procedures inside the body,” said MIT’s Ritu Raman. “Technically, muscles can power robots of any size, but we are particularly excited in making small robots, as this is where biological actuators excel in terms of strength, efficiency, and adaptability.”

Related Links:
MIT

Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Portable Patient Lift
Maxi Move
New
Clinical Display
C14S

Print article

Channels

Critical Care

view channel
Image: Tissue plasminogen activator working to dissolving brain clot and improving blood flow to the part of the brain being deprived (Photo courtesy of American Heart Association)

Injecting Clot-Dissolving Drug After Removing Large Brain Artery Clot Improves Stroke Outcomes

Approximately 1 in 5 ischemic strokes, which are caused by a clot, occur due to a blockage in a large artery in the brain (large vessel occlusions). The standard treatment for this type of stroke is the... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.